Plasmodium parasites use specialized ligands which bind to red blood cell (RBC) receptors during invasion. Defining the mechanism of receptor recognition is essential for the design of interventions against malaria. Here, we present the structural basis for Duffy antigen (DARC) engagement by P. vivax Duffy binding protein (DBP). We used NMR to map the core region of the DARC ectodomain contacted by the receptor binding domain of DBP (DBP-RII) and solved two distinct crystal structures of DBP-RII bound to this core region of DARC. Isothermal titration calorimetry studies show these structures are part of a multi-step binding pathway, and individual point mutations of residues contacting DARC result in a complete loss of RBC binding by DBP-RII. Two DBP-RII molecules sandwich either one or two DARC ectodomains, creating distinct heterotrimeric and heterotetrameric architectures. The DARC N-terminus forms an amphipathic helix upon DBP-RII binding. The studies reveal a receptor binding pocket in DBP and critical contacts in DARC, reveal novel targets for intervention, and suggest that targeting the critical DARC binding sites will lead to potent disruption of RBC engagement as complex assembly is dependent on DARC binding. These results allow for models to examine inter-species infection barriers, Plasmodium immune evasion mechanisms, P. knowlesi receptor-ligand specificity, and mechanisms of naturally acquired P. vivax immunity. The step-wise binding model identifies a possible mechanism by which signaling pathways could be activated during invasion. It is anticipated that the structural basis of DBP host-cell engagement will enable development of rational therapeutics targeting this interaction.
Vyšlo v časopise: Red Blood Cell Invasion by : Structural Basis for DBP Engagement of DARC. PLoS Pathog 10(1): e32767. doi:10.1371/journal.ppat.1003869 Kategorie: Research Article prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003869
1. MendisK, SinaBJ, MarchesiniP, CarterR (2001) The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64 : 97–106.
2. PriceRN, TjitraE, GuerraCA, YeungS, WhiteNJ, et al. (2007) Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77 : 79–87.
3. WelchSG, McGregorIA, WilliamsK (1977) The Duffy blood group and malaria prevalence in Gambian West Africans. Trans R Soc Trop Med Hyg 71 : 295–296.
4. HowesRE, PatilAP, PielFB, NyangiriOA, KabariaCW, et al. (2011) The global distribution of the Duffy blood group. Nat Commun 2 : 266.
5. MillerLH, MasonSJ, ClydeDF, McGinnissMH (1976) The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295 : 302–304.
6. WertheimerSP, BarnwellJW (1989) Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein. Exp Parasitol 69 : 340–350.
7. HorukR, ChitnisCE, DarbonneWC, ColbyTJ, RybickiA, et al. (1993) A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261 : 1182–1184.
8. GardnerL, PattersonAM, AshtonBA, StoneMA, MiddletonJ (2004) The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. Biochem Biophys Res Commun 321 : 306–312.
9. ToliaNH, EnemarkEJ, SimBK, Joshua-TorL (2005) Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 122 : 183–193.
10. ChitnisCE, MillerLH (1994) Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med 180 : 497–506.
11. CarltonJM, AdamsJH, SilvaJC, BidwellSL, LorenziH, et al. (2008) Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 455 : 757–763.
12. Beeson, Crabb (2007) Towards a vaccine against P. vivax malaria. PLoS Medicine 4: e337–e337.
13. XainliJ, BaisorM, KastensW, BockarieM, AdamsJH, et al. (2002) Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans. J Immunol 169 : 3200–3207.
14. XainliJ, Cole-TobianJL, BaisorM, KastensW, BockarieM, et al. (2003) Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein. Infect Immun 71 : 2508–2515.
15. Cole-TobianJL, MichonP, BiasorM, RichardsJS, BeesonJG, et al. (2009) Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children. Infect Immun 77 : 4009–4017.
16. GrimbergBT, UdomsangpetchR, XainliJ, McHenryA, PanichakulT, et al. (2007) Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med 4: e337.
17. ChootongP, NtumngiaFB, VanBuskirkKM, XainliJ, Cole-TobianJL, et al. (2010) Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Infect Immun 78 : 1089–1095.
18. KingCL, AdamsJH, XianliJ, GrimbergBT, McHenryAM, et al. (2011) Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria. Proc Natl Acad Sci U S A 108 : 20113–20118.
19. ChoeH, MooreMJ, OwensCM, WrightPL, VasilievaN, et al. (2005) Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). Mol Microbiol 55 : 1413–1422.
20. VanBuskirkKM, SevovaE, AdamsJH (2004) Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc Natl Acad Sci U S A 101 : 15754–15759.
21. HansD, PattnaikP, BhattacharyyaA, ShakriAR, YazdaniSS, et al. (2005) Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol Microbiol 55 : 1423–1434.
22. ChitnisCE, ChaudhuriA, HorukR, PogoAO, MillerLH (1996) The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J Exp Med 184 : 1531–1536.
23. TournamilleC, FilipeA, BadautC, RiottotM-M, LongacreS, et al. (2005) Fine mapping of the Duffy antigen binding site for the Plasmodium vivax Duffy-binding protein. Mol Biochem Parasitol 144 : 100–103.
24. MayorA, BirN, SawhneyR, SinghS, PattnaikP, et al. (2005) Receptor-binding residues lie in central regions of Duffy-binding-like domains involved in red cell invasion and cytoadherence by malaria parasites. Blood 105 : 2557–2563.
25. SinghSK, SinghAP, PandeyS, YazdaniSS, ChitnisCE, et al. (2003) Definition of structural elements in Plasmodium vivax and P. knowlesi Duffy-binding domains necessary for erythrocyte invasion. Biochem J 374 : 193–198.
26. BatchelorJD, ZahmJA, ToliaNH (2011) Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat Struct Mol Biol 18 : 908–914.
27. TournamilleC, Le Van KimC, GaneP, BlanchardD, ProudfootAE, et al. (1997) Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding. J Biol Chem 272 : 16274–16280.
28. SampathS, CarricoC, JanesJ, GurumoorthyS, GibsonC, et al. (2013) Glycan Masking of Plasmodium vivax Duffy Binding Protein for Probing Protein Binding Function and Vaccine Development. PLoS Pathog 9: e1003420.
29. DemoginesA, TruongKA, SawyerSL (2012) Species-specific features of DARC, the primate receptor for Plasmodium vivax and Plasmodium knowlesi. Mol Biol Evol 29 : 445–449.
30. LiuW, LiY, LearnGH, RudicellRS, RobertsonJD, et al. (2010) Origin of the human malaria parasite Plasmodium falciparum in gorillas. Nature 467 : 420–425.
31. XainliJ, AdamsJH, KingCL (2000) The erythrocyte binding motif of plasmodium vivax duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea. Mol Biochem Parasitol 111 : 253–260.
32. GosiP, KhusmithS, KhalambahetiT, LanarDE, SchaecherKE, et al. (2008) Polymorphism patterns in Duffy-binding protein among Thai Plasmodium vivax isolates. Malar J 7 : 112.
33. Nobrega de SousaT, CarvalhoLH, Alves de BritoCF (2011) Worldwide genetic variability of the Duffy binding protein: insights into Plasmodium vivax vaccine development. PLoS One 6: e22944.
34. NtumngiaFB, AdamsJH (2012) Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax Duffy binding protein. Clin Vaccine Immunol 19 : 30–36.
35. SiddiquiAA, XainliJ, SchloegelJ, CariasL, NtumngiaF, et al. (2012) Fine specificity of Plasmodium vivax Duffy binding protein binding engagement of the Duffy antigen on human erythrocytes. Infect Immun 80 : 2920–2928.
36. ChakeraA, SeeberRM, JohnAE, EidneKA, GreavesDR (2008) The Duffy Antigen/Receptor for Chemokines Exists in an Oligomeric Form in Living Cells and Functionally Antagonizes CCR5 Signaling through Hetero-Oligomerization. Molecular Pharmacology 73 : 1362–1370.
37. HodderAN, CzabotarPE, UboldiAD, ClarkeOB, LinCS, et al. (2012) Insights into Duffy binding-like domains through the crystal structure and function of the merozoite surface protein MSPDBL2 from Plasmodium falciparum. J Biol Chem 287 : 32922–32939.
38. LinDH, MalpedeBM, BatchelorJD, ToliaNH (2012) Crystal and solution structures of Plasmodium falciparum erythrocyte-binding antigen 140 reveal determinants of receptor specificity during erythrocyte invasion. J Biol Chem 287 : 36830–36836.
39. MalpedeBM, LinDH, ToliaNH (2013) Molecular basis for sialic acid-dependent receptor recognition by the Plasmodium falciparum invasion protein erythrocyte-binding antigen-140/BAEBL. J Biol Chem 288 : 12406–12415.
40. SinghSK, HoraR, BelrhaliH, ChitnisCE, SharmaA (2006) Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439 : 741–744.
41. SrinivasanP, YasgarA, LuciDK, BeattyWL, HuX, et al. (2013) Disrupting malaria parasite AMA1-RON2 interaction with a small molecule prevents erythrocyte invasion. Nat Commun 4 : 2261.
42. ChenE, PaingMM, SalinasN, SimBK, ToliaNH (2013) Structural and functional basis for inhibition of erythrocyte invasion by antibodies that target Plasmodium falciparum EBA-175. PLoS Pathog 9: e1003390.
43. KabschW (2010) Xds. Acta Crystallogr D Biol Crystallogr 66 : 125–132.
44. AdamsPD, AfoninePV, BunkocziG, ChenVB, DavisIW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66 : 213–221.
45. EmsleyP, LohkampB, ScottWG, CowtanK (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66 : 486–501.
46. DavisIW, Leaver-FayA, ChenVB, BlockJN, KapralGJ, et al. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35: W375–383.
47. KrissinelE, HenrickK (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372 : 774–797.
Zvýšte si kvalifikáciu online z pohodlia domova
Nemáte účet? Registrujte sa
Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
